Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis at Diagnosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

714 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-01

Study Completion Date

2024-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this international cohort study is to develop a prediction model for long-term outcome and response to first-line immunotherapy of anti-NMDAR Encephalitis, already at the moment of diagnosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Validation of a Diagnostic Score for Encephalitis to Assess the Risk of Autoimmune Origin

NCT05953974

Autoimmune Encephalitis Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)

UNKNOWN

Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare

NCT00423098

Lupus Nephritis

COMPLETED PHASE2

Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus

NCT00004665

Systemic Lupus Erythematosus

COMPLETED PHASE2

New Biomarkers in Auto-immune Encephalitis and Neurological Paraneoplastic Syndromes

NCT05728931

Paraneoplastic Neurological Syndrome Autoimmune Encephalitis

ACTIVE_NOT_RECRUITING

Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder

NCT05896605

NMO Spectrum Disorder Azathioprine Adverse Reaction

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anti-NMDARE is a severe, but treatable neurological condition, with considerable and variable long-term disability. The previously developed anti-NMDAR Encephalitis One-Year Functional Status (NEOS) score predicts outcome a month into treatment. To predict outcome and response to immunotherapy at the time of diagnosis would be a serious improvement. This would timely identify patients in need for aggressive treatment and avoid harmful side-effects in those with good outcome. International data from five anti-NMDAR encephalitis cohorts will be combined to attain these goals.

The investigators strive to have less than 10% missing data on all variables and will impute data were needed. The datasets will then be split - with equal distributions of cohorts and good/poor outcome - to develop (70%) and validate (30%) the NEOS2 model. The primary outcome is functioning one year after diagnosis. A secondary analysis is targeted to predict the effect of first-line therapy. Potentially relevant predictive variables are identified with a univariable analysis on the original data, confirmed with backwards selection on the imputed datasets. After checking for multicollinearity and linearity of the variables, identified variables are added to a mixed effects logistic regression model on the original and imputed datasets, to identify the final set of predictive variables. To make the models opportune for daily medical practice, the investigators will assign points to (categories of) the included variables, based on the coefficients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.